Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: crysball who wrote (654)	4/26/1998 10:57:00 AM
From: arnie h	of 1491

crysball; You're onto something as the potential for Lotemax and its offsprings seems most promising especially in light of the results just announced for post cataract surgery use. In addition, the company has a exciting head trauma candidate in the later stages of phase 2 trials and, according to some, a collaboration with a major outfit just around the corner. Sales for Lotemax are now due to start on June 1 and good money should be coming in. Yet, short sales have just jumped over 300,000 shares to 1+M sales short or some 500,000 shares over 2 months ago. Why would somebody short a $3 stock with the kind of potential we all think PARS has? Short sales are now at historic level for this stock. In the past, this has led to a good buying opportunity! Have a good weekend, Arnie

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next